TRXADE HEALTH INC (MEDS) Stock Price, Forecast & Analysis
USA - NASDAQ:MEDS - US89846A4058 - Common Stock
MEDS Key Statistics, Chart & Performance
The current stock price of MEDS is 7.59 USD. In the past month the price decreased by -8.22%. In the past year, price increased by 12.78%.
MEDS Latest News, Press Relases and Analysis
MEDS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.15 | 47.81B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.32 | 9.31B | ||
| WAY | WAYSTAR HOLDING CORP | 26.68 | 6.82B | ||
| HTFL | HEARTFLOW INC | N/A | 2.58B | ||
| CERT | CERTARA INC | 16.82 | 1.35B | ||
| PHR | PHREESIA INC | N/A | 1.35B | ||
| SDGR | SCHRODINGER INC | N/A | 1.27B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.25B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.77 | 1.07B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 628.5 | 1.06B | ||
| HSTM | HEALTHSTREAM INC | 36.13 | 728.25M |
Related stock screener links
About MEDS
Company Profile
TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
Company Info
TRXADE HEALTH INC
2420 Brunello Trace
Lutz FLORIDA 34639 US
CEO: Suren Ajjarapu
Employees: 8
Phone: 18002610281
TRXADE HEALTH INC / MEDS FAQ
Can you describe the business of TRXADE HEALTH INC?
TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
What is the stock price of TRXADE HEALTH INC today?
The current stock price of MEDS is 7.59 USD. The price increased by 4.83% in the last trading session.
Does TRXADE HEALTH INC pay dividends?
TRXADE HEALTH INC (MEDS) has a dividend yield of 125.16%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of MEDS stock?
MEDS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of TRXADE HEALTH INC (MEDS) based on its PE ratio?
TRXADE HEALTH INC (MEDS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.29).
When is the next dividend date for TRXADE HEALTH INC (MEDS)?
The next ex-dividend date for TRXADE HEALTH INC (MEDS) is July 19, 2024.
What is TRXADE HEALTH INC worth?
TRXADE HEALTH INC (MEDS) has a market capitalization of 11.08M USD. This makes MEDS a Nano Cap stock.
MEDS Technical Analysis
MEDS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MEDS. MEDS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MEDS Financial Highlights
Over the last trailing twelve months MEDS reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 63.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 94.17% | ||
| ROA | 28.09% | ||
| ROE | 35.39% | ||
| Debt/Equity | 0 |
MEDS Forecast & Estimates
7 analysts have analysed MEDS and the average price target is 6.89 USD. This implies a price decrease of -9.29% is expected in the next year compared to the current price of 7.59.
For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 4.1% for MEDS